← Back to Search

Use of Noona web- based symptom tracking tool for Quality of Life

N/A
Waitlist Available
Led By Kavitha Ramchandran, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial seeks to discover how well patients manage their symptoms and communicate with their care team when given a Noona account to log their symptoms.

Who is the study for?
This trial is for adults over 18 with advanced lung or gastrointestinal cancer, who can use a smartphone, tablet, or computer. They should be able to perform daily activities (ECOG status 0-2), have no limit on previous treatments in the metastatic setting, and are expected to live at least another 6 months. Non-English speakers and those with conditions that could interfere with participation or safety are excluded.Check my eligibility
What is being tested?
The study tests the Noona web-based symptom tracking tool's impact on patient engagement and quality of life. Participants will log symptoms regularly using their devices and complete a Symptom Questionnaire before oncology visits for real-time symptom management over a period of 24 weeks.See study design
What are the potential side effects?
Since this trial involves digital symptom tracking rather than medication or invasive procedures, there aren't typical side effects associated with drugs. However, participants may experience stress or anxiety from regular self-monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PROMIS-G (Patient-Reported Outcomes Measurement Information System-Global) mental subscale score
Change in PROMIS-G (Patient-Reported Outcomes Measurement Information System-Global) physical subscale score
Proportion of patients with at least one symptom questionnaire (SQ) completed after enrollment using the PROMIS platform
Secondary outcome measures
Average number of diary encounters
Change in overall Functional Assessment of Cancer Therapy-General (FACT-G) score
Proportion of clinicians that report satisfactory use of the Noona system
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Noona web-based symptom tracking toolExperimental Treatment1 Intervention
In addition to usual care for their disease, patients interact with Noona system and system questioners to record their symptoms over a period of 6 months.
Group II: Usual CareActive Control1 Intervention
Participants will receive the standard of care for their disease

Find a Location

Who is running the clinical trial?

Varian Medical SystemsIndustry Sponsor
58 Previous Clinical Trials
3,535 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,804 Total Patients Enrolled
Kavitha Ramchandran, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
2018. "Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05112198.
~10 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top